non-HDL cholesterol
Selected indexed studies
- Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. (Atherosclerosis, 2023) [PMID:37826864]
- The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. (Br J Nutr, 2016) [PMID:27724985]
- Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. (Am J Clin Nutr, 2018) [PMID:30239559]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. (2023) pubmed
- The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. (2016) pubmed
- Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. (2018) pubmed
- Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease? (2020) pubmed
- Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol. (2023) pubmed
- Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol. (2024) pubmed
- Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry. (2024) pubmed
- Non-HDL cholesterol as a therapeutic goal. (2019) pubmed
- Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation. (2025) pubmed
- The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms. (2024) pubmed